天灸疗法治疗非急性期虚证哮喘临床研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:
     客观评价天灸疗法治疗非急性期虚证哮喘的临床疗效,比较辨证取穴组及常规取穴组的疗效优劣,探讨天灸疗法辨证取穴治疗该病的临床价值及推广意义。
     方法:
     采用随机对照的研究方法,将符合纳入标准的60例非急性期哮喘患者分为辨证取穴组(试验组)与常规取穴组(对照组),试验组按辨证取穴,对照组按附院天灸常规取穴。两组患者均在初伏、中伏、末伏各治疗一次,共治疗三次。采用哮喘病人生存质量评定表(AQLQ)、哮喘控制测试量表(ACT)及哮喘症状积分表进行疗效评价,分别于治疗前、治疗后(完成三次三伏天灸治疗)及6个月后随访三个时间点进行量表评定。
     结果:
     两组患者治疗前基线资料比较,经统计学分析具有可比性(P>0.05)。经三次三伏天灸治疗,试验组治疗后与治疗前比较,AQLQ积分、ACT积分提高,哮喘症状积分降低,差异均有统计学意义(P<0.01),6个月后与治疗后比较,AQLQ积分、ACT积分有所下降,哮喘症状积分有所升高,差异均有统计学意义(P<0.01),但6个月后与治疗前比较,AQLQ积分、ACT积分仍然提高,哮喘症状积分仍然降低,差异均有统计学意义(P<0.01),对照组治疗后与治疗前比较,AQLQ积分、ACT积分提高,哮喘症状积分降低,差异均有统计学意义(P<0.01),6个月后与治疗后比较,AQLQ积分、ACT积分下降,哮喘症状积分升高,差异均有统计学意义(P<0.01),6个月后与治疗前比较,AQLQ积分、ACT积分虽有提高,哮喘症状积分虽有降低,但差异均无统计学意义(P>0.05),不同评定时间,AQLQ积分、ACT积分、哮喘症状积分两组间变化趋势比较,差异均有统计学意义(P<0.05)。提示试验组与对照组均能提高非急性期哮喘患者生存质量、控制哮喘发作,缓解哮喘症状,但试验组疗效优于对照组,且试验组的疗效维持时间长于对照组。
     结论:
     针对非急性期虚证哮喘患者,辨证取穴与常规取穴均能提高哮喘病人生存质量,控制哮喘发作,缓解哮喘症状,但相比常规取穴,辨证取穴效果更优,疗效维持时间更长,同时辨证取穴也符合了中医学辨证论治基本特点,故当大力提倡并应用于临床。
Objective
     Objective evaluation of the clinical efficacy of Tianjiu Therapy on asthma with deficient syndrome in non-acute phase. By comparing the Dialectical Acupoints Group with the Conventional Acupoints Group, we explore the clinical value and the significance of popularization of the Tianjiu Therapy on this disease by Acupoints selection based on symdrome differentiation.
     Method
     Adopting random and compared research methods, sixty cases that met the inclusion criteria are divided into two groups, Symdrome Different Acupoints Group(Experimental Group) and Conventional Acupoints Group(Control Group). The Experimental Group selected acupoints based on symdrome differentiation, while the Control Group selected acupoints according to conventional acupoints of affiliated hospital. All patients in the two groups were treated three times, each treatment in Chufu, Zhongfu, Mofu. To evaluat the efficacy We adopted the Asthma Quality of Life Questionnaire, the Asthma Control Test and the Sympt-om of Asthma score, then filled the scales at the time of Before-treatment, After-treatment, complete three treatments, and Six-months-after-treatment.
     Results
     Baseline data of the two groups before treatment were comparable(P>0.05) by statistical analysis. After three treatments by Sanfu Tianjiu Therapy, Afte-r-treatment of Experimental Group compared with Before-treatment, the AQLQ score and ACT score were higher, the Symptom of Asthma score was lower, the differences were statistically significant (P<0.01), Six-months-after-treatm-ent compared with Afer-treatment, the AQLQ score and ACT score were decreased, the Symptom of Asthma score was increased, the differences were statistically significant (P<0.01), but Six-months-after-treatment compared with Before-tr eatment, the AQLQ score and ACT score were still higher, the Symptom of Asthma score was still lower, the differences were statistically significant (P<0.01), while Afer-treatment of Control Group compared with Before treatment, the AQLQ score and ACT score were higher, the Symptom of Asthma score was lower, the differences were statistically significant (P<0.01), Six-months-after-treat-ment compared with Afer-treatment, the AQLQ score and ACT score were decreased, the Symptom of Asthma score was increased, the differences were statistically significant (P<0.01), Six-months-after-treatment compared with Be fore-treatm-ent, although the AQLQ score and the ACT score were higher, the Symptom of Asthma score was lower, the differences were not statistically significant (P>0.05). Compared with different assessments,the differences between the two groups of the improvement trends of AQLQ score, ACT score and the Symptom of Asthma score were statistically significant (P<0.05). Those suggested that both the Experimental Group and Control Group can improve the AQLQ score and ACT score, reduce the Symptom of Asthma score. Hower, Experimental Group is better than Control Group, and the efficacy of Experimental Group was maintained longer than Control Group.
     Conclusion
     For asthma patients with deficient symdrome in non-acute phase, both the Acupoints Selection based on symdrome differentiation and Acupoints Selection based on convention can significantly improve patients'life quality, enhance asthma control, and ease asthma symptoms. But the efficacy of Acupoints select-ion based on symdrome differentiation is better and maintained longer than the_Acupoints Selection based on convention, while Acupoints Selection based on symdrome differentiation is in line with the basic characteristics of the TCM, which is called treatment based on symdrome diffentiation. So, it should be strongly advocated and used in the clinical.
引文
[1]王吉耀.内科学[M].北京:人民卫生出版社,2005.7:49.
    [2]罗笑容.儿科专病中医临床诊治[M].北京:人民卫生出版社,2000:10.
    [3]姚英.天灸治疗支气管哮喘98例[J].中国中医急症,2011,20(4):652.
    [4]李小明.天灸疗法在社区慢性阻塞性肺疾病缓解期病人中的应用[J].护理研究,2010,4,(12):3187-3188.
    [5]符翠婷,李明亮,陈俊琦.临床观察三九天灸疗法对过敏性鼻炎的短期疗效[J].浙江中医药大学学报,2011,35(2):255-257.
    [6]王庆波.天灸法治疗脾胃虚寒型胃脘痛56例[J].河南中医,2009,29(6):600.
    [7]李悦殉.举陷理气汤配合天灸疗法治疗胃下垂疗效观察[J].现代中西医结合杂志,2010,19(3):309-310.
    [8]耿丽梅,马晓莉,刘红燕.天灸疗法对溃疡性结肠炎缓解期的疗效观察[J].医学研究与教育,2011,28(2):53-56.
    [9]吴雁,张燕,张兴荣,陈迎龙.三伏灸治疗小儿慢性支气管炎临床疗效观察及护理[J].护士进修杂志,2009,24(22):2109-2110.
    [10]张震.发泡疗法治疗小儿口疮120例[J].中医外治杂志,1999,8(4):24-25.
    [11高艳秋.天灸疗法治疗陈旧性踝关节扭伤35例[J].江西中医药,2008,39(304):63.
    [12]樊丽君,崔占义,孙树枝.天灸配合药物治疗痛风性关节炎疗效观察[J].上海针灸杂志,2011,30(9):612-614.
    [13]周四熊,左玉初.发泡疗法治疗类风湿性关节炎36例[J].湖南中医杂志,2000,16(5):35.
    [14]徐勇,凌敬,林仕群.天灸治疗纤维肌痛综合征42例[J].中医外治杂志,2010,19(3):45.
    [15]何广武,金贤为.天灸法治疗带状疱疹后遗神经痛45例疗效观察[J].上海针灸杂志,2006,25(11):26-27.
    [16]张峰.天灸疗法治疗面神经麻痹24例[J].湖北中医杂志,2000,22(3):46-47.
    [17]李庚丑,商联合,夏英杰.中药穴位发泡疗法治疗梅核气38例临床观察[J].中国针灸,1999,(2):85-86.
    [18]晏行三.“发泡疗法”外治神经性皮炎17例[J].中医外治杂志,1999,8(1):53-54.
    [19]李卫红,徐绍东.白芥子发泡疗法治疗白癜风疗效观察[J].中国美容医学,2001,10(1):108-110.
    [20]刘玉环,张仁尊,崔淑杰.天灸治疗硬皮病[J].针灸临床杂志,1997,13(3):39-40.
    [21]郑茜,金晶,宋晓平.天灸血清对过敏性哮喘大鼠肺脏和脾脏中CD4+、CD8的影响[J].新疆中医药,2010,28(6):7-9.
    [22]戴文军,赖新生.天灸疗法对支气管哮喘患者血浆SP和VIP含量的影响[J].针刺研究,2001,26(2):134-137.
    [23]周丽莎,涂乾,朱书秀.天灸对潜伏期及发作期过敏性哮喘大鼠血清IgE和下丘脑室旁核白细胞介素1的作用[J].中国临床康复,2005,9(15):134-135.
    [24]王颖,李学武,赵立岩,李南玲.天灸对肺癌小鼠骨髓有核细胞和外周白细胞的影响及其抗肿瘤 作用[J].中国临床康复,2006,10(11):132-134.
    [25]魏伟,吴成.中医对哮喘病因病机及发作期冷热分型认识初探[J].现代中西医结合杂志,2004,13(11):1443-1445.
    [26]钟伟明.中医辨证治疗支气管哮喘的临床分析[J].中外医疗,2009,24:107-108.
    [27]邵长荣.支气管哮喘辨证用药心法[J].中医文献杂志,1995,(2):33-35.
    [28]周静.哮喘的脏腑论治[J].四川中医,2003,21(3):9-10.
    [29]邢向晖,王晓宁.小儿哮喘从痰论治六则[J].中国医药学报,2002,17(4):232-233.
    [30]麻日明.小青龙汤加味治疗冷哮53例[J].光明中医,2009,24(11):2195-2196.
    [31]李明星.支哮发作方治疗支气管哮喘急性发作58例疗效观察[J].甘肃中医,2006,19(4):22-23
    [32]袁雪晶.汪受传教授从肺脾气虚论治儿童哮喘缓解期经验[N].中医药导报,2009,15(11):8-9.
    [33]马荣芳,苏显红.扶正固本汤治疗支气管哮喘缓解期临床观察[J].实用中医内科杂志,2009,23(5):42-43.
    [34]曾凡若,曾凡芝.中药黄芪辅助治疗儿童支气管哮喘合并反复呼吸道感染疗效观察[J].湖北中医杂志,2009,31(12):11-12.
    [35]王妍炜.中药雾化吸人治疗小儿哮喘发作疗效观察[J].中国中医急症,2006,15(8):832、839.
    [36]王璇珠,吴前方.鱼腥草雾化吸入辅助治疗小儿支气管哮喘的疗效观察[J].河北医学,2004,10(7):601-603.
    [37]周志荣.中药直肠滴入治疗婴幼儿哮喘50例[N].浙江中医学院学报,2005,29(5):44.
    [38]米建平,刘炳权,符文彬等.天灸疗法防治支气管哮喘181例疗效观察[J].新中医,2005,37(2):61-62.
    [39]单翠英,林忠嗣,卞镝.中药穴位贴敷治疗儿童哮喘的临床及免疫机制研究[J].中华中医药学刊,2007,15(4):845-846.
    [40]励志英.针灸治疗支气管哮喘临床选穴机理浅析[J].江苏中医药,2008,40(10):73.
    [41]张文彭,E. B. BJIaHMHpCKHf i, A. B. TyeB, B. JI. KyqepcKHfi针刺对支气管哮喘患者临床症状与肺功能的影响[J].中国针灸,2006,26(11):763-767.
    [42]蒋向东.针刺翳风治疗哮喘急性发作60例[J].中国针灸,2002.22(9):61.
    [43]贝时英,章伟平.麝香灸治疗顽固性哮喘103例[J].中医外治杂志,1999,8(6):15.
    [44]李硅.壮医药线点灸疗法治疗肺虚哮喘临床效果观察[J].中国针灸,2005,25(3):181-183.
    [45]仝斌.穴位注射治疗支气管哮喘临床观察[J].中国中医急症,2007,16(6):656、670.
    [46]徐建勇,高洪英.天突穴位注射治疗小儿支气管哮喘72例[J].中国针灸,2005,25(6):416.
    [47]张文义.平行针药线介入治疗支气管哮喘100例[J].中医外治杂志,2007,16(1):38-39.
    [48]王晋新.辨证论治合穴位敷贴法防治儿童哮喘疗效观察[J].山西中医,2009,25(12):17-18.
    [49]马红,肖晓桃,郑芙蓉.自拟方配合三伏天灸治疗支气管哮喘缓解期疗效观察[J].中医药临床杂志,2009,21(6):537-538.
    [50]The global initiative for asthma. Global strategy for asthma management and prevention: mechanisms of asthma[M]. NewYork:National institutes of health,2002:50-54
    [51]Holgate ST, Lackie PM, Davies DE, et al.The bronchial epithelium as a key regulator of airway allergy sensitization and remodeling in asthma[J].Am J Respir Crit Care Med,2000,162:S113-S117.
    [52]Akizama H. Airway epithelial cells as regulators of airway inflammatory[J]Int J Mol Med,1998,1:367-378.
    [53]Trennard SI. Repairmechanisms in asthma[J].Jallergy Clin Immunol,1996,98,278-286.
    [54]赵顺英.哮喘发病机制研究进展[J].实用儿科临床杂志,2003,18(10):768-771.
    [55]马红珍.白三烯拮抗剂对咳嗽变异性哮喘的防治效果观察[J].临床肺科杂志,2009,14(5):689.
    [56]邵向荣.吸人抗胆碱药物治疗老年哮喘的疗效观察[J].中国民康医学,2007,19(11):936、985.
    [57]Barnes PJ. Vasoactive Intestinal Peptide Stimulates Tracheal Submucosal Gland Secretion in Ferret. Trends Pharmol Sci,1981,8:24.
    [58]Barnes PJ. Effect of Nedocromil Sodium or Plate-activating Factor Induced Airway Responses. J Allergy Clin Immunol,1993,92:187.
    [59]王明明,陈四文等.中药穴位敷贴对幼龄哮喘豚鼠血清超氧化物歧化酶、丙二醛和白细胞介素5的影响[J].北京中医药大学学报(中医临床版),2005,(1):1-3.
    [60]王艳杰,唐纯志,王升旭.穴位贴敷天灸透皮吸收剂对哮喘豚鼠血清肿瘤坏死因子a的影响[J].中国组织工程研究与临床康复,2008,12(45):8847-8849.
    [61]张毅敏,赖新生,唐纯志等.穴位敷贴对支气管哮喘豚鼠肿瘤坏死因子及白细胞介素2的影响[J].中国临床康复,2005,9(27):104-105.
    [62]廖韩波,唐纯志,黄泳等.穴位贴敷经皮给药药贴对哮喘豚鼠血清中IL-4水平的影响[J].南方医科大学学报,2009,29(3):565-567.
    [63]张玉英,阴智敏,盛刚等.止喘贴对哮喘大鼠血清中IL-5、IL-12表达的影响[J].陕西中医,2009,30(11):1555-1556.
    [64]Robinson DS, Durham SR,Kay AB. Cytokines in asthma [J]. Thorax, t993,48:845-853.
    [65]单翠英,林忠嗣,卞镝中药穴位贴敷治疗儿童哮喘的临床及免疫机制研究[J].中华中医药学刊,2007,2(4):845-846.
    [66]Finotto S, Glimcher L. T cell directives for transcriptional regulation in asthma[J]. Springer Semin Immunol,2004,25(3-4):281.
    [67]董亮,张琦,陈明等.转录因子T-bet/GATA-3比率评价哮喘患者Thl/Th2失衡及CPG ODN干预机制的研究[J].中国病理生理杂志,2007,23(9):1776.
    [68]李月梅,刘强,黄丰,李艳慧.穴位敷贴对哮喘小鼠相关转录因子的调控作用[J].广州中医药大学学报,2001,28(5):488-490、498.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700